Brain cancer linked to nerve agent
For the first time, a study has found an increase in brain cancer deaths among Gulf War veterans who might have been exposed to the nerve agent sarin by the destruction of Iraqi weapons in 1991. »
Wednesday, Jul. 27, 2005
New clues in prostate cancer therapy
Two new studies could help men and their doctors better treat prostate cancer. »
Sunday, Jul. 24, 2005
Skin cancer breakthrough in an egg
Chicken eggs containing a drug that can target and treat skin cancer have been produced by Scottish scientists. »
Saturday, Jul. 23, 2005
Single drug dose effective after cancer surgery
After surgery, a single dose of carboplatin appears to be just as effective in preventing relapse as three weeks of radiation therapy in men with early-stage testicular cancer, according to the findings of a study published in this week’s issue of The Lancet. Carboplatin also appears to be associated with less severe adverse effects and lower risk of developing a tumor in the other testicle. »
Friday, Jul. 22, 2005
Yeast unravels cancer conundrum
A simple ingredient used to bake bread has helped scientists unravel a complex problem in the fight against cancer. »
Thursday, Jul. 21, 2005
Testicular cancer drug effective
A single dose of a drug is as effective at treating testicular cancer as two to three weeks of radiotherapy, research has found. »
Monday, Jul. 11, 2005
In cancer fight, a spice brings hope to the table
The University of Texas M.D. Anderson Cancer Center, the epitome of the conventional cancer establishment, is reporting promising test results on an unconventional weapon: a common spice used in Indian cooking. »
Friday, Jul. 1, 2005
Cancer ‘fertility predictor’ test
UK researchers say they have found a way to forecast how long women will be fertile after being treated for cancer. »
Tuesday, Jun. 28, 2005
Gene clues give new insight into lung cancer
Researchers have found new clues about the location of genes potentially involved in the most common type of lung cancer, which may suggest a range of possible targets for development of future therapies. »
Monday, Jun. 27, 2005
Cervical cancer vaccine in final testing stage
A vaccine developed by scientists at the University of Rochester Medical Centre to prevent cervical cancer is in the final stages of testing, says a report in the university website. »
Saturday, Jun. 25, 2005
Moffitt finds new use for cancer-fighting drug
The H. Lee Moffitt Cancer Center & Research Institute said it expects to begin clinical trials in six to eight months on a drug that could add another weapon in the arsenal against several cancers. »
Thursday, Jun. 23, 2005
Beatson breakthrough hope: stop cancer in its tracks
Scientists in Glasgow have announced a major breakthrough which could help stop cancer in its tracks. »
Wednesday, Jun. 22, 2005
‘Common virus kills cancer cells’
A common virus that is harmless to humans can destroy cancerous cells and could be developed into a new cancer therapy, researchers said. »
Sunday, Jun. 19, 2005
Tumour cured in 8 weeks
When Jon Giannarelli was told he had a tumour, he thought he was going to die. »
Saturday, Jun. 18, 2005
Scientists Discover Lung Cell Linked to Cancer
A newly identified kind of lung stem cell may be the source of the most common kinds of lung cancers, a new study suggests. »
Trial of cancer drug shows promise for breast, prostate, bowel, kidney, skin and ovarian cancers
Promising results from the UK’s first clinical trial of a prototype cancer drug have raised the prospect of an effective new treatment against a range of cancers, including breast, prostate, bowel, kidney, ovarian and skin cancer. »
Cancer vaccines in final test phase
More than a dozen cancer vaccines are now in the final phase of human testing, the last step before Food and Drug Administration approval is sought for marketing. »
New gene chip may be early cancer diagnosis tool
A pilot study at the National Institute of Standards and Technology (NIST), in support of the National Cancer Institute’s Early Detection Research Network (EDRN), has validated the measurement accuracy of new techniques that use mitochondrial DNA as an early indicator for certain types of cancer. Additional results suggest that a relatively simple diagnostic test using a DNA microarray “chip” could enable early detection of some solid tumors, including lung cancer. »
Targeted Therapies Begin to Make Dent in Cancer’s Armor
The dream of targeted cancer therapy is irresistible: »
Thursday, Jun. 16, 2005
Roche says US clears new use for oral cancer drug
Roche Holding AG won U.S. approval on Wednesday to market its oral chemotherapy drug Xeloda for post-surgical treatment of patients with colon cancer that has spread to the lymph nodes, the company said. »
You can call ‘em lung-cancer bloodhounds
If all goes as planned in the Wistar Institute laboratory of Dr. David W. Speicher, he will one daywalk into his physician’s office for a routine checkup and wait patiently while his doctor draws an extra tube of blood. »
Wednesday, Jun. 15, 2005
Sunlight exposure may cut prostate cancer risk
A new study suggests the more sun a man gets, the smaller his chances of developing prostate cancer. In fact, more exposure could reduce that risk by as much as half. »
A simple blood test to detect breast cancer
A team of scientists has developed a simple blood test, which can detect breast cancer even before the symptoms appear. »
Tuesday, Jun. 14, 2005
Handheld breast cancer detector in development
Scientists in the U.S. are testing a handheld device they believe holds great promise in helping women, in the comfort of their own home, detect breast cancer early. »
Monday, Jun. 13, 2005
True cancer-causing genes revealed by new technique
Often cancer research goes like this: study cancerous cells in a lab dish, find mutations that appear in many of the samples, develop drugs to target proteins made by the mutated genes, and voila, new chemotherapy drugs are born. Or at least that’s the hope. »
Delaying radiation for prostate cancer does not affect outcome
For men diagnosed with prostate cancer, there is no risk of recurrence if external beam radiation therapy (EBRT) is delayed by several months. A study published in the July 15, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society, finds delays of EBRT had no harmful impact on clinical outcome or biochemical marker levels in low-, intermediate- and high-risk patients. »
Sunday, Jun. 12, 2005
Curcumin in turmeric may curb breast cancer spread
Turmeric powder, which is commonly used in Indian cooking, contains a chemical called Curcumin, which may help curb breast cancer from spreading, a new research has revealed. »
Cancer fight grows $300,000 stronger after Relay for Life
The tents have been packed away and the walkers have gone home, but the 2005 American Cancer Society Relays for Life in Porter County aren’t quite over. »
Wednesday, Jun. 8, 2005
Cure for Chemobrain, a relief for Cancer patients
Researchers at the University of Cincinnati have developed a new treatment which can help Cancer patients suffering with the problem of Chemobrain ; a common consequence of chemotherapy that causes memory problems,confusion and difficulty in concentrating. »
Cancer aid in oily fish
Oily fish is being used to develop a breast cancer superdrug, doctors revealed yesterday. »